HealthcareServices

Biopharmaceutical Third-Party Logistics Market 2026–2030: Forecasting Business Opportunities Ahead

February 20, 2026February 20, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the biopharmaceutical third-party logistics market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the Biopharmaceutical Third-Party Logistics Market from 2026 to 2030?

The biopharmaceutical third-party logistics market has demonstrated robust expansion over recent years. Projections indicate it will grow from $150.5 billion in 2025 to $161.71 billion in 2026, at a compound annual growth rate (CAGR) of 7.4%. The market’s past growth is linked to factors such as the increase in biologics and vaccine production, a rise in pharmaceutical companies outsourcing their logistics services, the expansion of global biopharmaceutical supply chains, heightened regulatory demands for drug transportation, and biopharma firms possessing limited in-house logistics capabilities.

Significant expansion is anticipated for the biopharmaceutical third-party logistics market size over the coming years. The market is projected to reach $221.15 billion by 2030, driven by a compound annual growth rate (CAGR) of 8.1%. This growth during the forecast period is attributable to several factors, including the rising demand for personalized medicines, the broadening of cell and gene therapy distribution, increased investments in smart logistics platforms, a heightened emphasis on end-to-end supply chain visibility, and the expansion of cross-border biopharmaceutical trade. Key trends expected within the forecast timeframe encompass the wider adoption of advanced cold chain logistics solutions, an escalating demand for temperature-monitored transportation services, the increasing deployment of real-time shipment tracking platforms, the expansion of specialized biopharma warehousing infrastructure, and a stronger emphasis on regulatory-compliant logistics operations.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12616&type=smp

What Drivers Are Affecting Demand In The Biopharmaceutical Third-Party Logistics Market?

The increasing adoption of logistics outsourcing is anticipated to fuel the expansion of the biopharmaceutical third-party logistics market. This practice entails entrusting an external entity with the management of some or all of a firm’s logistical operations. Within biopharmaceutical third-party logistics, outsourcing logistics finds application in delegating cryogenic supply chain management to specialized logistics partners. As an illustration, in February 2024, data from the Bureau of Transportation Statistics, a US-based division of the Department of Transportation (DOT), indicated that for-hire freight shipments experienced a 1.8% increase in December 2023 relative to December 2022. Concurrently, the Freight Transportation Services Index climbed from 136.6 in December 2022 to 139.1 in December 2023. Consequently, the expanding practice of outsourcing logistics is projected to spur the advancement of the biopharmaceutical third-party logistics market.

Which Segments Are Gaining Traction In The Biopharmaceutical Third-Party Logistics Market?

The biopharmaceutical third-party logistics market covered in this report is segmented –

1) By Supply Chain: Cold Chain, Non-Cold Chain

2) By Service: Transportation, Warehousing And Storage, Other Services

3) By End-User: Pharmaceutical And Biopharmaceutical Companies, Medical Device Companies, Hospitals And Clinics, Other End-Users

Subsegments:

1) By Cold Chain: Refrigerated Transport, Temperature-Controlled Storage, Specialized Packaging

2) By Non-Cold Chain: Ambient Transport, Standard Storage Solutions, General Packaging Methods

Which Trends Are Shaping Activity Within The Biopharmaceutical Third-Party Logistics Market?

Major companies in the biopharmaceutical third-party logistics market are prioritizing innovative strategies, such as expanding into life sciences and healthcare logistics, to bolster their capabilities for pharmaceutical and healthcare products, ensuring efficient storage and distribution. This business expansion in life sciences and healthcare logistics refers to the strategic growth of logistics firms to enhance their capacity in transporting and managing medical goods, which is critical for guaranteeing timely delivery and maintaining the integrity of temperature-sensitive items essential for patient care. For instance, in May 2025, DHL Group, a logistics company based in Germany, announced the grand opening of its upgraded Life Sciences & Healthcare (LSH) campus in Florstadt, Germany. The new facility features ultra-cold storage zones (down to –70°C), real-time visibility systems, and GDP-certified infrastructure, enabling the secure handling of temperature-sensitive biopharmaceuticals, including mRNA vaccines, clinical trial materials, and advanced therapies.

Who Are The Prominent Global Companies Shaping The Biopharmaceutical Third-Party Logistics Market Landscape?

Major companies operating in the biopharmaceutical third-party logistics market are McKesson Corporation, AmerisourceBergen Corporation, United Parcel Service of America Inc., FedEx Corporation, DHL International GmbH, Kuehne + Nagel International AG, SF Express Co Ltd., DB Schenker, CH Robinson Worldwide Inc., Nippon Express Group, Expeditors International of Washington Inc., Sinotrans Limited, XPO Logistics Inc., Kerry Logistics Network Limited, Bollore Logistics, VersaCold Logistics Services, Cryoport Inc., Agility Logistics Corp, Fisher Clinical Services, CEVA Logistics Inc., LifeScience Logistics, Cold Chain Technologies LLC, Langham Logistics, Airpharm Logistics, Express Courier International, Bio Pharma Logistics

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-third-party-logistics-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Biopharmaceutical Third-Party Logistics Market?

North America was the largest region in the biopharmaceutical third party logistics market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical third-party logistics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Biopharmaceutical Third-Party Logistics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12616&type=smp

Browse Through More Reports Similar to the Global Biopharmaceutical Third-Party Logistics Market 2026, By The Business Research Company

Third Party Logistics 3Pl Market 2026

https://www.thebusinessresearchcompany.com/report/third-party-logistics-3pl-market

Biopharmaceutical Third Party Logistics Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-third-party-logistics-global-market-report

Pharmaceutical Logistics Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-logistics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795